NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) Stock Rating Upgraded by Zacks Investment Research

NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports.

According to Zacks, “Nissan Chemical Corporation is a chemical manufacturing company. It offers melamine, sulfuric acid, nitric acid and ammonia; fine chemicals, including special epoxy, flame retardant and disinfectant. Nissan Chemical Corporation, formerly known as Nissan Chemical Industries Ltd., is based in Tokyo, Japan. “

NNCHY opened at $45.19 on Thursday. The firm has a market capitalization of $6.73 billion, a price-to-earnings ratio of 25.39, a price-to-earnings-growth ratio of 2.26 and a beta of 0.53. NISSAN CHEM IND/ADR has a 52 week low of $41.85 and a 52 week high of $54.81. The stock’s 50 day moving average price is $43.25. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.90 and a current ratio of 3.10.

NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) last announced its earnings results on Wednesday, May 15th. The company reported $0.64 earnings per share for the quarter. The company had revenue of $572.13 million during the quarter. On average, sell-side analysts predict that NISSAN CHEM IND/ADR will post 2 earnings per share for the current fiscal year.

About NISSAN CHEM IND/ADR

Nissan Chemical Corporation engages in chemicals, performance materials, agricultural chemicals, pharmaceuticals, and advanced materials and planning businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, a urea solution; FINEOXOCOL, a saturated fatty alcohol and acid; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a flame retardant; Nissan Reishi, a health food; phenylphosphonic acid, a surface modifier; HI-LITE, a chlorinated isocyanulate; and OPTBEADS, a melamine-formaldehyde resin and silica.

Featured Story: Conference Calls and Individual Investors

Get a free copy of the Zacks research report on NISSAN CHEM IND/ADR (NNCHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NISSAN CHEM IND/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NISSAN CHEM IND/ADR and related companies with MarketBeat.com's FREE daily email newsletter.